- Home
- GRX vs ELEV Comparison
GRX vs ELEV Comparison
Compare GRX & ELEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRX
- ELEV
- Stock Information
- Founded
- GRX 2007
- ELEV 2019
- Country
- GRX United States
- ELEV United States
- Employees
- GRX N/A
- ELEV N/A
- Industry
- GRX Finance/Investors Services
- ELEV Biotechnology: Pharmaceutical Preparations
- Sector
- GRX Finance
- ELEV Health Care
- Exchange
- GRX Nasdaq
- ELEV Nasdaq
- Market Cap
- GRX 160.8M
- ELEV 155.7M
- IPO Year
- GRX N/A
- ELEV 2021
- Fundamental
- Price
- GRX $11.08
- ELEV $0.63
- Analyst Decision
- GRX
- ELEV Strong Buy
- Analyst Count
- GRX 0
- ELEV 5
- Target Price
- GRX N/A
- ELEV $7.80
- AVG Volume (30 Days)
- GRX 39.7K
- ELEV 846.8K
- Earning Date
- GRX 01-01-0001
- ELEV 10-31-2024
- Dividend Yield
- GRX 5.98%
- ELEV N/A
- EPS Growth
- GRX N/A
- ELEV N/A
- EPS
- GRX 0.26
- ELEV N/A
- Revenue
- GRX N/A
- ELEV N/A
- Revenue This Year
- GRX N/A
- ELEV N/A
- Revenue Next Year
- GRX N/A
- ELEV N/A
- P/E Ratio
- GRX $38.50
- ELEV N/A
- Revenue Growth
- GRX N/A
- ELEV N/A
- 52 Week Low
- GRX $7.73
- ELEV $0.36
- 52 Week High
- GRX $10.40
- ELEV $5.83
- Technical
- Relative Strength Index (RSI)
- GRX 69.73
- ELEV 21.64
- Support Level
- GRX $10.68
- ELEV $0.70
- Resistance Level
- GRX $11.14
- ELEV $0.80
- Average True Range (ATR)
- GRX 0.13
- ELEV 0.07
- MACD
- GRX -0.00
- ELEV 0.06
- Stochastic Oscillator
- GRX 78.43
- ELEV 5.80
About GRX The Gabelli Healthcare & Wellness Trust of Beneficial Interest
Gabelli Healthcare & WellnessRx Trust operates as a diversified closed-end management investment company. The investment objective of the fund is the long-term growth of capital. The fund invests at least its assets in equity securities and income-producing securities of domestic and foreign companies in the healthcare and wellness industries. It invests in various sectors, of which Health Care Providers & Services, Food, Health Care Equipment and Supplies, and Pharmaceuticals account for the majority of the weightage.
About ELEV Elevation Oncology Inc. Common stock
Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.